EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of the Dietary Supplement 5α‐Hydroxy‐Laxogenin in the Orchiectomized Rat Model

Daniel Derwand iD, Oliver Zierau iD, Clemens Alexander Wolf, Gerhard Wolber iD, Annekathrin Martina Keiler iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Daniel Derwand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany. Hauptthemen laut MEDLINE: Dietary Supplements, Anabolic Agents, Androgens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dietary supplements used by recreational and elite athletes for performance enhancement might contain undeclared, unlawfully added ingredients. One of those ingredients is 5α‐hydroxy‐laxogenin, which is sold in dietary supplements marketed as a natural compound with anabolic effects. It has been shown that 5α‐hydroxy‐laxogenin is not naturally occurring, but rather of synthetic origin. Previously, we observed that 5α‐hydroxy‐laxogenin can bind to and activate the androgen receptor in a cell‐based bioassay. To investigate its androgenic potential in vivo, we treated orchiectomized rats with three different dosages of 5α‐hydroxy‐laxogenin for 2 weeks. Effects were neither observed on the wet weights of the androgen target tissues prostate, seminal vesicle or penis nor on the wet weights of the anabolic target tissue musculus levator ani or on skeletal hindlimb muscles. Au contraire, significantly higher atrophy was seen for some of the target tissues in the animals treated with the highest 5α‐hydroxy‐laxogenin dosage (36 mg/kg bw). While in silico docking supports the androgen receptor binding previously observed in vitro, we observed neither androgenic nor anabolic effects of 5α‐hydroxy‐laxogenin in vivo in castrated male rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsAnabolic AgentsAndrogensAnimalsMaleOrchiectomyRatsReceptors, AndrogenMuscle, SkeletalRats, Sprague-DawleyOrgan SizeMolecular Docking SimulationProstate

Stichwörter der Autor:innen

Hershberger assaydopingmolecular modelling

Substanzen

Receptors, AndrogenAnabolic AgentsAndrogens

Autor:innen und Institutionen

  • Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany.
  • Faculty of Biology, Environmental Monitoring & Endocrinology, Technische Universität Dresden, Dresden, Germany.
  • Molecular Design Lab, Institute of Pharmacy, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Berlin, Germany.

ORCID-Profile: Daniel Derwand, Oliver Zierau, Gerhard Wolber, Annekathrin Martina Keiler

Zitieren

APA

Derwand, D., Zierau, O., Wolf, C. A., Wolber, G., & Keiler, A. M. (2025). Effects of the Dietary Supplement 5α‐Hydroxy‐Laxogenin in the Orchiectomized Rat Model. Drug Testing and Analysis. https://doi.org/10.1002/dta.3881

Vancouver

Derwand D, Zierau O, Wolf CA, Wolber G, Keiler AM. Effects of the Dietary Supplement 5α‐Hydroxy‐Laxogenin in the Orchiectomized Rat Model. Drug Testing and Analysis. 2025. doi:10.1002/dta.3881

BibTeX
@article{Derwand2025,
  author = {Derwand, Daniel and Zierau, Oliver and Wolf, Clemens Alexander and Wolber, Gerhard and Keiler, Annekathrin Martina},
  title = {Effects of the Dietary Supplement 5α‐Hydroxy‐Laxogenin in the Orchiectomized Rat Model},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3881}
}
Kostenlos starten →